New Zealand markets open in 21 minutes

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
518.77+7.94 (+1.55%)
At close: 4:00PM EDT
518.77 0.00 (0.00%)
After hours: 04:05PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close510.83
Open513.33
Bid518.30 x 1100
Ask520.28 x 800
Day's range508.48 - 520.52
52-week range250.24 - 543.85
Volume168,800
Avg. volume330,332
Market cap20.356B
Beta (5Y monthly)1.12
PE ratio (TTM)149.50
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.28 (0.25%)
Ex-dividend date13 Aug 2021
1y target estN/A
All
News
  • GlobeNewswire

    Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021

    NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today reported financial results for the quarter and nine months ended March 31, 2021. Recent Highlights Partnership announced with University of Utah health system to improve kidney health and reduce the risk of kidney failure for large-scale populations in the earliest stages of kidney disease. KidneyIntelX to be integrated with the university electronic health records (EHR) s

  • Business Wire

    908 Devices and Bio-Techne Announce Joint Collaboration

    908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple branded protein analysis portfolio of products, will pair its Maurice icIEF separation instrument with 908 Devices’ ZipChip device to deliver a seamless workflow for deeper protein characterization. Maurice and the iCE technology are the gold standard in protein characterization, providing absorbance and native fluorescence icIEF detection as well as CE-SDS, saving significant development time and reducing the time to commercialization.